Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease

Conclusions
This replicated study suggests potential utility of the studied CAV1 SNP as a genetic biomarker in CKD and a role for CAV1 in the development of arteriosclerosis in this setting. Further studies are warranted to further explore the basic science driving these clinical observations.

Source: Nephrology Dialysis Transplantation - June 21, 2016 Category: Urology & Nephrology Authors: Chand, S., Edwards, N. C., Chue, C. D., Jesky, M., Stringer, S., Simmonds, M. J., Duff, C. E., Cockwell, P., Harper, L., Steeds, R. P., Townend, J. N., Ferro, C. J., Borrows, R. Tags: Chronic Kidney Disease Source Type: research